Differences in the Impact of Covid-19 on Pathology Laboratories and Cancer Diagnosis in Girona

Bibliographic Data

ID15513173
AuthorsArantza Sanvisens (0000-0001-6269-5491, Fundación Josep Carreras Contra la Leucemia), Montse Puigdemont (0000-0001-9961-3699, Institut Català d'Oncologia), Jordi Rubió‐Casadevall (0000-0002-3516-6970, Universitat de Girona), Jordi Rubió-Casadevall (Institut d’Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), 17004 Girona, Spain), Anna Vidal‐Vila (Institut Català d'Oncologia), Anna Vidal-Vila (Epidemiology Unit and Girona Cancer Registry, Institut Català d’Oncologia, Pla Director d’Oncologia, 17004 Girona, Spain), Eugeni López‐Bonet (0000-0002-9199-0702, Hospital Universitari de Girona Doctor Josep Trueta), Eugeni López-Bonet (Department of Pathology, Hospital Universitari Dr. Josep Trueta, 17007 Girona, Spain), Ferran Martín-Romero (Fundació Salut i Envelliment UAB), Rafael Marcos-Gragera (0000-0001-9824-3657, Universitat de Girona, corresponding author)
Year2021
Volume18
Issue24
Pages13269-13269
Publication date2021-12-16
Open AccessYes
TypeARTICLE
VenueInternational Journal of Environmental Research and Public Health (JOURNAL)
Journal identifiersISSN: 1661-7827 • E-ISSN: 1660-4601
PublisherMultidisciplinary Digital Publishing Institute (PUBLISHER • CH)
DOI10.3390/ijerph182413269
PMID34948878
OpenAlexW4200301754
LanguageEN
References cited40

The COVID-19 pandemic has resulted in a reduction in cancer diagnoses by pathology departments that varies according to tumor location and type of hospital. Despite this, the optimization of care resources and the recovery effort have partially reduced the impact of the pandemic in certain neoplasms

Cancer · Malignancy · Medical diagnosis · Pathology · COVID-19 and healthcare impacts · Genital Health and Disease · Infection Control and Ventilation · Medicine · Internal Medicine

Tools

Open DOIOpen Access